RNU4-60P

Across TCGA pan-cancer cohorts, RNU4-60P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU4-60P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RNU4-60P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU4-60P expression acts as an unfavorable survival marker, although some lineages such as SARC and BLCA show a favorable association.

READ, LIHC, and PAAD are the cancer types where RNU4-60P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	II,III,IV	0.173	0.818	<.001	99	view →
LIHC	OS	Tertile	All	0.051	0.775	<.001	90	view →
PAAD	OS	Tertile	All	0.202	0.481	.003	45	view →
SKCM	DFS	Tertile	III,IV	0.214	0.659	.002	36	view →
SARC	DFS	Tertile	All	1.000	0.325	.006	21	view →
BLCA	DFS	Tertile	IV	0.877	0.393	.028	12	view →
LUSC	DFS	Tertile	II,III,IV	0.139	0.663	.027	12	view →
THCA	OS	Tertile	II,III,IV	0.724	0.903	.032	12	view →
GBM	DFS	Tertile	All	0.591	0.226	.047	9	view →
BRCA	DFS	Tertile	II,III,IV	0.833	0.892	.049	3	view →
STAD	OS	Quartile	II,III,IV	0.760	0.653	.044	2	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU4-60P–READ (OS)

Open the READ breakdown →